Global Orthopedics Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Market 2023 by Manufacturers, Regions, Type and Application, Forecast to 2029
1 Market Overview
- 1.1 Product Overview and Scope of Orthopedics Nonsteroidal Anti-Inflammatory Drugs (NSAIDs)
- 1.2 Market Estimation Caveats and Base Year
- 1.3 Market Analysis by Type
- 1.3.1 Overview: Global Orthopedics Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Consumption Value by Type: 2018 Versus 2022 Versus 2029
- 1.3.2 Injection Type
- 1.3.3 Oral Type
- 1.3.4 Others
- 1.4 Market Analysis by Application
- 1.4.1 Overview: Global Orthopedics Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Consumption Value by Application: 2018 Versus 2022 Versus 2029
- 1.4.2 Hospital
- 1.4.3 Clinic
- 1.4.4 Others
- 1.5 Global Orthopedics Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Market Size & Forecast
- 1.5.1 Global Orthopedics Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Consumption Value (2018 & 2022 & 2029)
- 1.5.2 Global Orthopedics Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Sales Quantity (2018-2029)
- 1.5.3 Global Orthopedics Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Average Price (2018-2029)
2 Manufacturers Profiles
- 2.1 Merck
- 2.1.1 Merck Details
- 2.1.2 Merck Major Business
- 2.1.3 Merck Orthopedics Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Product and Services
- 2.1.4 Merck Orthopedics Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
- 2.1.5 Merck Recent Developments/Updates
- 2.2 Bayer
- 2.2.1 Bayer Details
- 2.2.2 Bayer Major Business
- 2.2.3 Bayer Orthopedics Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Product and Services
- 2.2.4 Bayer Orthopedics Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
- 2.2.5 Bayer Recent Developments/Updates
- 2.3 JandJ
- 2.3.1 JandJ Details
- 2.3.2 JandJ Major Business
- 2.3.3 JandJ Orthopedics Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Product and Services
- 2.3.4 JandJ Orthopedics Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
- 2.3.5 JandJ Recent Developments/Updates
- 2.4 GSK
- 2.4.1 GSK Details
- 2.4.2 GSK Major Business
- 2.4.3 GSK Orthopedics Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Product and Services
- 2.4.4 GSK Orthopedics Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
- 2.4.5 GSK Recent Developments/Updates
- 2.5 Septodont
- 2.5.1 Septodont Details
- 2.5.2 Septodont Major Business
- 2.5.3 Septodont Orthopedics Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Product and Services
- 2.5.4 Septodont Orthopedics Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
- 2.5.5 Septodont Recent Developments/Updates
- 2.6 Roche
- 2.6.1 Roche Details
- 2.6.2 Roche Major Business
- 2.6.3 Roche Orthopedics Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Product and Services
- 2.6.4 Roche Orthopedics Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
- 2.6.5 Roche Recent Developments/Updates
- 2.7 PerioChip
- 2.7.1 PerioChip Details
- 2.7.2 PerioChip Major Business
- 2.7.3 PerioChip Orthopedics Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Product and Services
- 2.7.4 PerioChip Orthopedics Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
- 2.7.5 PerioChip Recent Developments/Updates
- 2.8 Sunstar
- 2.8.1 Sunstar Details
- 2.8.2 Sunstar Major Business
- 2.8.3 Sunstar Orthopedics Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Product and Services
- 2.8.4 Sunstar Orthopedics Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
- 2.8.5 Sunstar Recent Developments/Updates
- 2.9 Colgate-Palmolive
- 2.9.1 Colgate-Palmolive Details
- 2.9.2 Colgate-Palmolive Major Business
- 2.9.3 Colgate-Palmolive Orthopedics Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Product and Services
- 2.9.4 Colgate-Palmolive Orthopedics Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
- 2.9.5 Colgate-Palmolive Recent Developments/Updates
- 2.10 DenMat
- 2.10.1 DenMat Details
- 2.10.2 DenMat Major Business
- 2.10.3 DenMat Orthopedics Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Product and Services
- 2.10.4 DenMat Orthopedics Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
- 2.10.5 DenMat Recent Developments/Updates
- 2.11 Showa Yakuhin Kako
- 2.11.1 Showa Yakuhin Kako Details
- 2.11.2 Showa Yakuhin Kako Major Business
- 2.11.3 Showa Yakuhin Kako Orthopedics Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Product and Services
- 2.11.4 Showa Yakuhin Kako Orthopedics Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
- 2.11.5 Showa Yakuhin Kako Recent Developments/Updates
3 Competitive Environment: Orthopedics Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) by Manufacturer
- 3.1 Global Orthopedics Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Sales Quantity by Manufacturer (2018-2023)
- 3.2 Global Orthopedics Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Revenue by Manufacturer (2018-2023)
- 3.3 Global Orthopedics Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Average Price by Manufacturer (2018-2023)
- 3.4 Market Share Analysis (2022)
- 3.4.1 Producer Shipments of Orthopedics Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) by Manufacturer Revenue ($MM) and Market Share (%): 2022
- 3.4.2 Top 3 Orthopedics Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Manufacturer Market Share in 2022
- 3.4.2 Top 6 Orthopedics Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Manufacturer Market Share in 2022
- 3.5 Orthopedics Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Market: Overall Company Footprint Analysis
- 3.5.1 Orthopedics Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Market: Region Footprint
- 3.5.2 Orthopedics Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Market: Company Product Type Footprint
- 3.5.3 Orthopedics Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Market: Company Product Application Footprint
- 3.6 New Market Entrants and Barriers to Market Entry
- 3.7 Mergers, Acquisition, Agreements, and Collaborations
4 Consumption Analysis by Region
- 4.1 Global Orthopedics Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Market Size by Region
- 4.1.1 Global Orthopedics Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Sales Quantity by Region (2018-2029)
- 4.1.2 Global Orthopedics Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Consumption Value by Region (2018-2029)
- 4.1.3 Global Orthopedics Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Average Price by Region (2018-2029)
- 4.2 North America Orthopedics Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Consumption Value (2018-2029)
- 4.3 Europe Orthopedics Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Consumption Value (2018-2029)
- 4.4 Asia-Pacific Orthopedics Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Consumption Value (2018-2029)
- 4.5 South America Orthopedics Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Consumption Value (2018-2029)
- 4.6 Middle East and Africa Orthopedics Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Consumption Value (2018-2029)
5 Market Segment by Type
- 5.1 Global Orthopedics Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Sales Quantity by Type (2018-2029)
- 5.2 Global Orthopedics Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Consumption Value by Type (2018-2029)
- 5.3 Global Orthopedics Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Average Price by Type (2018-2029)
6 Market Segment by Application
- 6.1 Global Orthopedics Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Sales Quantity by Application (2018-2029)
- 6.2 Global Orthopedics Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Consumption Value by Application (2018-2029)
- 6.3 Global Orthopedics Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Average Price by Application (2018-2029)
7 North America
- 7.1 North America Orthopedics Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Sales Quantity by Type (2018-2029)
- 7.2 North America Orthopedics Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Sales Quantity by Application (2018-2029)
- 7.3 North America Orthopedics Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Market Size by Country
- 7.3.1 North America Orthopedics Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Sales Quantity by Country (2018-2029)
- 7.3.2 North America Orthopedics Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Consumption Value by Country (2018-2029)
- 7.3.3 United States Market Size and Forecast (2018-2029)
- 7.3.4 Canada Market Size and Forecast (2018-2029)
- 7.3.5 Mexico Market Size and Forecast (2018-2029)
8 Europe
- 8.1 Europe Orthopedics Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Sales Quantity by Type (2018-2029)
- 8.2 Europe Orthopedics Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Sales Quantity by Application (2018-2029)
- 8.3 Europe Orthopedics Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Market Size by Country
- 8.3.1 Europe Orthopedics Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Sales Quantity by Country (2018-2029)
- 8.3.2 Europe Orthopedics Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Consumption Value by Country (2018-2029)
- 8.3.3 Germany Market Size and Forecast (2018-2029)
- 8.3.4 France Market Size and Forecast (2018-2029)
- 8.3.5 United Kingdom Market Size and Forecast (2018-2029)
- 8.3.6 Russia Market Size and Forecast (2018-2029)
- 8.3.7 Italy Market Size and Forecast (2018-2029)
9 Asia-Pacific
- 9.1 Asia-Pacific Orthopedics Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Sales Quantity by Type (2018-2029)
- 9.2 Asia-Pacific Orthopedics Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Sales Quantity by Application (2018-2029)
- 9.3 Asia-Pacific Orthopedics Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Market Size by Region
- 9.3.1 Asia-Pacific Orthopedics Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Sales Quantity by Region (2018-2029)
- 9.3.2 Asia-Pacific Orthopedics Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Consumption Value by Region (2018-2029)
- 9.3.3 China Market Size and Forecast (2018-2029)
- 9.3.4 Japan Market Size and Forecast (2018-2029)
- 9.3.5 Korea Market Size and Forecast (2018-2029)
- 9.3.6 India Market Size and Forecast (2018-2029)
- 9.3.7 Southeast Asia Market Size and Forecast (2018-2029)
- 9.3.8 Australia Market Size and Forecast (2018-2029)
10 South America
- 10.1 South America Orthopedics Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Sales Quantity by Type (2018-2029)
- 10.2 South America Orthopedics Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Sales Quantity by Application (2018-2029)
- 10.3 South America Orthopedics Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Market Size by Country
- 10.3.1 South America Orthopedics Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Sales Quantity by Country (2018-2029)
- 10.3.2 South America Orthopedics Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Consumption Value by Country (2018-2029)
- 10.3.3 Brazil Market Size and Forecast (2018-2029)
- 10.3.4 Argentina Market Size and Forecast (2018-2029)
11 Middle East & Africa
- 11.1 Middle East & Africa Orthopedics Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Sales Quantity by Type (2018-2029)
- 11.2 Middle East & Africa Orthopedics Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Sales Quantity by Application (2018-2029)
- 11.3 Middle East & Africa Orthopedics Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Market Size by Country
- 11.3.1 Middle East & Africa Orthopedics Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Sales Quantity by Country (2018-2029)
- 11.3.2 Middle East & Africa Orthopedics Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Consumption Value by Country (2018-2029)
- 11.3.3 Turkey Market Size and Forecast (2018-2029)
- 11.3.4 Egypt Market Size and Forecast (2018-2029)
- 11.3.5 Saudi Arabia Market Size and Forecast (2018-2029)
- 11.3.6 South Africa Market Size and Forecast (2018-2029)
12 Market Dynamics
- 12.1 Orthopedics Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Market Drivers
- 12.2 Orthopedics Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Market Restraints
- 12.3 Orthopedics Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Trends Analysis
- 12.4 Porters Five Forces Analysis
- 12.4.1 Threat of New Entrants
- 12.4.2 Bargaining Power of Suppliers
- 12.4.3 Bargaining Power of Buyers
- 12.4.4 Threat of Substitutes
- 12.4.5 Competitive Rivalry
- 12.5 Influence of COVID-19 and Russia-Ukraine War
- 12.5.1 Influence of COVID-19
- 12.5.2 Influence of Russia-Ukraine War
13 Raw Material and Industry Chain
- 13.1 Raw Material of Orthopedics Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) and Key Manufacturers
- 13.2 Manufacturing Costs Percentage of Orthopedics Nonsteroidal Anti-Inflammatory Drugs (NSAIDs)
- 13.3 Orthopedics Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Production Process
- 13.4 Orthopedics Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Industrial Chain
14 Shipments by Distribution Channel
- 14.1 Sales Channel
- 14.1.1 Direct to End-User
- 14.1.2 Distributors
- 14.2 Orthopedics Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Typical Distributors
- 14.3 Orthopedics Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Typical Customers
15 Research Findings and Conclusion
16 Appendix
- 16.1 Methodology
- 16.2 Research Process and Data Source
According to our (Global Info Research) latest study, the global Orthopedics Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) market size was valued at USD 235.6 million in 2022 and is forecast to a readjusted size of USD 320.6 million by 2029 with a CAGR of 4.5% during review period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
This report is a detailed and comprehensive analysis for global Orthopedics Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) market. Both quantitative and qualitative analyses are presented by manufacturers, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2023, are provided.
Key Features:
Global Orthopedics Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) market size and forecasts, in consumption value ($ Million), sales quantity (K Units), and average selling prices (US$/Unit), 2018-2029
Global Orthopedics Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) market size and forecasts by region and country, in consumption value ($ Million), sales quantity (K Units), and average selling prices (US$/Unit), 2018-2029
Global Orthopedics Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) market size and forecasts, by Type and by Application, in consumption value ($ Million), sales quantity (K Units), and average selling prices (US$/Unit), 2018-2029
Global Orthopedics Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) market shares of main players, shipments in revenue ($ Million), sales quantity (K Units), and ASP (US$/Unit), 2018-2023
The Primary Objectives in This Report Are:
To determine the size of the total market opportunity of global and key countries
To assess the growth potential for Orthopedics Nonsteroidal Anti-Inflammatory Drugs (NSAIDs)
To forecast future growth in each product and end-use market
To assess competitive factors affecting the marketplace
This report profiles key players in the global Orthopedics Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) market based on the following parameters - company overview, production, value, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Merck, Bayer, JandJ, GSK and Septodont, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, COVID-19 and Russia-Ukraine War Influence.
Market Segmentation
Orthopedics Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) market is split by Type and by Application. For the period 2018-2029, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type
Injection Type
Oral Type
Others
Market segment by Application
Hospital
Clinic
Others
Major players covered
Merck
Bayer
JandJ
GSK
Septodont
Roche
PerioChip
Sunstar
Colgate-Palmolive
DenMat
Showa Yakuhin Kako
Market segment by region, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
South America (Brazil, Argentina, Colombia, and Rest of South America)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Orthopedics Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top manufacturers of Orthopedics Nonsteroidal Anti-Inflammatory Drugs (NSAIDs), with price, sales, revenue and global market share of Orthopedics Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) from 2018 to 2023.
Chapter 3, the Orthopedics Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) competitive situation, sales quantity, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Orthopedics Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) breakdown data are shown at the regional level, to show the sales quantity, consumption value and growth by regions, from 2018 to 2029.
Chapter 5 and 6, to segment the sales by Type and application, with sales market share and growth rate by type, application, from 2018 to 2029.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales quantity, consumption value and market share for key countries in the world, from 2017 to 2022.and Orthopedics Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) market forecast, by regions, type and application, with sales and revenue, from 2024 to 2029.
Chapter 12, market dynamics, drivers, restraints, trends, Porters Five Forces analysis, and Influence of COVID-19 and Russia-Ukraine War.
Chapter 13, the key raw materials and key suppliers, and industry chain of Orthopedics Nonsteroidal Anti-Inflammatory Drugs (NSAIDs).
Chapter 14 and 15, to describe Orthopedics Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) sales channel, distributors, customers, research findings and conclusion.